Application
GANAB Antibody (N-term) western blot analysis in MDA-MB435 cell line lysates (15ug/lane).This demonstrates the GANAB antibody detected the GANAB protein (arrow).Application
GANAB Antibody (N-term) western blot analysis in mouse NIH-3T3 cell line lysates (15ug/lane).This demonstrates the GANAB antibody detected the GANAB protein (arrow).| Product Name | GANAB Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | G2AN, KIAA0088 |
|---|---|
| Alternative Names | GANAB G2AN KIAA0088 Neutral alpha-glucosidase AB Alpha-glucosidase 2 Glucosidase II subunit alpha |
| Molecular Weight(MW) | 106874 Da |
| Function | Cleaves sequentially the 2 innermost alpha-1,3-linked glucose residues from the Glc(2)Man(9)GlcNAc(2) oligosaccharide precursor of immature glycoproteins |
| Tissue Specificity | Detected in placenta. |
| Cellular Localization | Endoplasmic reticulum (By similarity). Golgi apparatus (By similarity). Melanosome. Note=Identified by mass spectrometry in melanosome fractions from stage I to stage IV |
| Entrez Gene | 23193 |
|---|---|
| Nucleotide Accession | NP_938148.1 |
Application
GANAB Antibody (N-term) western blot analysis in MDA-MB435 cell line lysates (15ug/lane).This demonstrates the GANAB antibody detected the GANAB protein (arrow).
Application
GANAB Antibody (N-term) western blot analysis in mouse NIH-3T3 cell line lysates (15ug/lane).This demonstrates the GANAB antibody detected the GANAB protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
